2025 Esmo Tat. ESMO 2024 Mint Medical GmbH The ESMO Targeted Anticancer Therapies Congress 2025 took place from 3 to 5 March 2025 in Paris, France This multi-stakeholder forum brought together researchers, industry partners, investors, and regulatory bodies under the same roof, making the event essential for any professional involved in the development of new anticancer drugs
ESMO Asia 2023 Reasons to attend this international oncology congress for AsiaPacific YouTube from www.youtube.com
The ESMO Colloquia are innovative sessions within the Congress programme that bring together top experts to discuss evolving areas of interest to the oncology community. The Daily Reporter is a service from ESMO, Europe's leading medical oncology society
ESMO Asia 2023 Reasons to attend this international oncology congress for AsiaPacific YouTube
The Opening Session & 2025 TAT Honorary Award on March 3 set the stage for this year's Targeted Anticancer Therapies Congress in Paris The Daily Reporter is a service from ESMO, Europe's leading medical oncology society This multi-stakeholder forum brought together researchers, industry partners, investors, and regulatory bodies under the same roof, making the event essential for any professional involved in the development of new anticancer drugs
ESMO 2023 Archives VJOncology. The ESMO TAT Congress is dedicated to improving the conduct of early phase clinical trials in oncology by providing the latest scientific breakthroughs as well as workshops and educational reviews on pre-clinical. Welcome to the ESMO TAT Congress 2025 by the Scientific Co-Chairs
ESMO 2023 Archives VJOncology. The Daily Reporter is a service from ESMO, Europe's leading medical oncology society The ESMO TAT Congress is dedicated to improving the conduct of early phase clinical trials in oncology by providing the latest scientific breakthroughs as well as workshops and educational reviews on pre-clinical and early clinical data.ESMO TAT 2025 is a multi-stakeholder forum in the early drug development arena, which bring together investigators from academia, translational scientists.